Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
0.0002
%
3,23%
Latest
0.0064
High
0.0064
Low
0.0058
Volume
42 959 771
Turnover (SEK)
258 940
Market Value (MSEK)
20,3
Time (Latest trade)

Board

CEO

  • Tore Duvold

Chairperson of the Board

  • Ulrik Spork

Board

  • Christina Östberg Lloyd
  • Ingela Liljeqvist Soltic
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Largest Owners

Name Capital % Votes % Date
Mount Nebo Capital 24,95 24,95 2025-03-04
Avanza Pension 12,40 12,40 2025-06-26
Nordnet Pensionsförsäkring 9,71 9,71 2025-06-26
UNITY Innovation Alliance AG 5,17 5,17 2025-03-04
Henrik Ruö Jensen 3,76 3,76 2025-06-26
Michael Kantor 3,46 3,46 2025-06-26
Peter Nilsson 3,33 3,33 2025-06-26
Flexmedical Solutions Limited 3,08 3,08 2025-03-31
John Moll 2,59 2,59 2025-06-26
Per Robert Anderson 2,36 2,36 2025-06-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream